| 3.2 |
9.5 |
GO:0046959 |
habituation(GO:0046959) |
| 2.6 |
41.0 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 2.2 |
6.6 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 1.7 |
3.4 |
GO:0021636 |
trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
| 1.6 |
6.4 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 1.6 |
6.3 |
GO:1901204 |
positive regulation of guanylate cyclase activity(GO:0031284) regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 1.5 |
10.4 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 1.4 |
4.3 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 1.3 |
4.0 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 1.3 |
18.0 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 1.3 |
6.4 |
GO:0030242 |
pexophagy(GO:0030242) |
| 1.2 |
1.2 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 1.2 |
10.4 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 1.2 |
2.3 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 1.1 |
4.5 |
GO:1903802 |
L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
| 1.1 |
3.4 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 1.1 |
5.6 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 1.1 |
5.5 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 1.1 |
1.1 |
GO:0072197 |
renal vesicle induction(GO:0072034) ureter morphogenesis(GO:0072197) |
| 1.1 |
4.2 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 1.0 |
2.0 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 1.0 |
4.8 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.9 |
2.8 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 0.9 |
2.8 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.9 |
2.8 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.9 |
3.7 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.9 |
4.6 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.9 |
7.3 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.9 |
2.7 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.9 |
2.7 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 0.9 |
3.6 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.9 |
2.7 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 0.9 |
4.4 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.9 |
2.6 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.9 |
0.9 |
GO:1903061 |
regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 0.9 |
5.1 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.8 |
4.1 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.8 |
2.4 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.8 |
2.4 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.8 |
3.1 |
GO:0031622 |
positive regulation of fever generation(GO:0031622) |
| 0.7 |
2.2 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.7 |
2.2 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 0.7 |
4.3 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 0.7 |
10.0 |
GO:0021540 |
corpus callosum morphogenesis(GO:0021540) |
| 0.7 |
2.1 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 0.7 |
1.4 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.7 |
2.1 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.7 |
2.1 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.7 |
2.1 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.7 |
2.1 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.7 |
2.0 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 0.7 |
2.7 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.7 |
2.7 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.7 |
2.7 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.7 |
2.0 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 0.7 |
2.0 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.7 |
11.7 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.6 |
2.5 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.6 |
3.8 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.6 |
1.9 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.6 |
1.2 |
GO:1905005 |
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 0.6 |
1.9 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.6 |
5.0 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.6 |
1.9 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.6 |
4.3 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.6 |
2.4 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.6 |
1.8 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.6 |
1.8 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.6 |
1.2 |
GO:0031652 |
positive regulation of heat generation(GO:0031652) |
| 0.6 |
6.9 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.6 |
2.2 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.6 |
4.4 |
GO:2000809 |
positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.6 |
3.9 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.5 |
3.3 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.5 |
2.2 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.5 |
2.2 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.5 |
5.2 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.5 |
4.1 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.5 |
1.5 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.5 |
18.4 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.5 |
4.0 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.5 |
1.5 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) lateral motor column neuron migration(GO:0097477) |
| 0.5 |
2.0 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.5 |
1.5 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.5 |
1.5 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.5 |
2.9 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.5 |
2.4 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.5 |
1.4 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.5 |
3.8 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.5 |
2.8 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.5 |
1.4 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.5 |
2.8 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.5 |
3.7 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.5 |
0.5 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.5 |
4.2 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.5 |
1.4 |
GO:0070649 |
formin-nucleated actin cable assembly(GO:0070649) |
| 0.4 |
1.3 |
GO:1902277 |
negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.4 |
1.8 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.4 |
1.8 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.4 |
2.2 |
GO:0090273 |
regulation of somatostatin secretion(GO:0090273) |
| 0.4 |
5.3 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.4 |
0.4 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 0.4 |
5.3 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.4 |
5.7 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.4 |
1.3 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.4 |
1.3 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.4 |
1.2 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.4 |
0.8 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.4 |
3.2 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.4 |
7.3 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.4 |
3.1 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.4 |
0.8 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.4 |
3.9 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.4 |
0.8 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.4 |
1.2 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.4 |
0.4 |
GO:1902947 |
regulation of tau-protein kinase activity(GO:1902947) |
| 0.4 |
3.8 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.4 |
1.9 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.4 |
0.7 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.4 |
4.4 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.4 |
1.5 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.4 |
1.8 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) |
| 0.4 |
6.2 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.4 |
1.8 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.4 |
1.1 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.4 |
1.4 |
GO:1903423 |
positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.4 |
1.4 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.3 |
4.2 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.3 |
1.7 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.3 |
1.3 |
GO:0007066 |
female meiosis sister chromatid cohesion(GO:0007066) |
| 0.3 |
13.0 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 0.3 |
1.0 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.3 |
1.0 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.3 |
0.3 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.3 |
2.0 |
GO:0046880 |
regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 0.3 |
1.0 |
GO:0060468 |
prevention of polyspermy(GO:0060468) |
| 0.3 |
8.5 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.3 |
2.3 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 0.3 |
2.6 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.3 |
1.3 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.3 |
2.2 |
GO:0015840 |
urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
| 0.3 |
1.3 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.3 |
0.9 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.3 |
1.9 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.3 |
0.9 |
GO:2001170 |
positive regulation of fat cell proliferation(GO:0070346) negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.3 |
4.4 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.3 |
2.8 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.3 |
4.0 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.3 |
0.9 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.3 |
3.0 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.3 |
0.6 |
GO:0010748 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.3 |
0.9 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.3 |
1.5 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.3 |
1.8 |
GO:0046103 |
ADP biosynthetic process(GO:0006172) inosine biosynthetic process(GO:0046103) |
| 0.3 |
0.9 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.3 |
0.6 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.3 |
3.2 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.3 |
1.7 |
GO:0002591 |
positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
| 0.3 |
0.9 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.3 |
9.5 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.3 |
2.8 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.3 |
1.7 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.3 |
6.9 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.3 |
0.8 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.3 |
1.1 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.3 |
0.8 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.3 |
1.1 |
GO:0034374 |
low-density lipoprotein particle remodeling(GO:0034374) |
| 0.3 |
0.8 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.3 |
2.2 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.3 |
0.8 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.3 |
0.5 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.3 |
1.1 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.3 |
0.8 |
GO:0043416 |
regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.3 |
7.8 |
GO:0009268 |
response to pH(GO:0009268) |
| 0.3 |
2.0 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.3 |
2.3 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.3 |
3.8 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.2 |
1.0 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.2 |
1.2 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) |
| 0.2 |
0.2 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.2 |
0.7 |
GO:0009838 |
abscission(GO:0009838) positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.2 |
1.7 |
GO:2001258 |
negative regulation of cation channel activity(GO:2001258) |
| 0.2 |
1.5 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.2 |
2.9 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.2 |
0.7 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.2 |
0.7 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.2 |
1.7 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.2 |
0.7 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.2 |
1.0 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 |
2.1 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.2 |
4.0 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.2 |
2.8 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.2 |
4.2 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.2 |
1.2 |
GO:1903044 |
protein localization to membrane raft(GO:1903044) |
| 0.2 |
0.7 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 |
2.3 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.2 |
1.8 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.2 |
2.0 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.2 |
2.0 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.2 |
2.0 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.2 |
2.0 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.2 |
0.9 |
GO:0072362 |
regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) |
| 0.2 |
0.6 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.2 |
3.4 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.2 |
0.9 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.2 |
0.9 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.2 |
1.1 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.2 |
1.9 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.2 |
0.6 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.2 |
1.5 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.2 |
0.2 |
GO:0045852 |
pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.2 |
0.4 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.2 |
2.3 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.2 |
0.6 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.2 |
2.0 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.2 |
0.6 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.2 |
5.7 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.2 |
1.2 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.2 |
0.4 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.2 |
1.8 |
GO:0008054 |
negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
| 0.2 |
0.8 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.2 |
6.6 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.2 |
0.4 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.2 |
0.6 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.2 |
4.9 |
GO:2001240 |
negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.2 |
1.3 |
GO:0021681 |
cerebellar granular layer development(GO:0021681) |
| 0.2 |
0.6 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.2 |
3.7 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.2 |
1.8 |
GO:0010713 |
negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.2 |
2.0 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.2 |
1.6 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.2 |
0.7 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.2 |
0.7 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.2 |
0.4 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.2 |
3.7 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.2 |
2.7 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.2 |
0.7 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.2 |
0.9 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.2 |
1.2 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.2 |
1.7 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.2 |
0.9 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.2 |
0.3 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.2 |
1.0 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.2 |
2.7 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.2 |
1.0 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.2 |
2.7 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.2 |
0.8 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.2 |
0.5 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.2 |
0.3 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.2 |
1.7 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.2 |
0.8 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.2 |
0.6 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.2 |
0.5 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.2 |
1.0 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.2 |
3.6 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.2 |
0.3 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.2 |
0.2 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.2 |
0.6 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.2 |
0.6 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.2 |
1.7 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.1 |
0.9 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.1 |
0.7 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.1 |
0.4 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.1 |
0.1 |
GO:1905154 |
negative regulation of membrane invagination(GO:1905154) |
| 0.1 |
1.8 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.1 |
0.4 |
GO:0035336 |
long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
| 0.1 |
0.6 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 |
5.2 |
GO:0047496 |
vesicle transport along microtubule(GO:0047496) |
| 0.1 |
1.0 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.1 |
1.2 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.1 |
0.9 |
GO:0046579 |
positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.1 |
0.4 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.1 |
4.4 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.1 |
2.0 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 |
0.1 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.1 |
1.2 |
GO:1904587 |
glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
| 0.1 |
1.8 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.1 |
1.1 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.1 |
4.8 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
0.4 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.1 |
2.6 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.1 |
0.3 |
GO:0060965 |
negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.1 |
1.1 |
GO:0032261 |
purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
| 0.1 |
0.4 |
GO:0051580 |
regulation of neurotransmitter uptake(GO:0051580) |
| 0.1 |
1.5 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 |
0.5 |
GO:1904192 |
cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 0.1 |
0.4 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 |
0.9 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
3.5 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.1 |
0.6 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.1 |
0.9 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.1 |
1.3 |
GO:0002098 |
tRNA wobble uridine modification(GO:0002098) |
| 0.1 |
0.5 |
GO:0055119 |
relaxation of cardiac muscle(GO:0055119) |
| 0.1 |
8.1 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 |
0.6 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
| 0.1 |
0.4 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.1 |
3.1 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.1 |
0.5 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 0.1 |
0.5 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.1 |
0.4 |
GO:0070944 |
neutrophil mediated killing of bacterium(GO:0070944) |
| 0.1 |
2.8 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
0.5 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.1 |
1.8 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.1 |
0.5 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 |
0.4 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 |
0.8 |
GO:0035646 |
endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.1 |
1.0 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.1 |
0.7 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.1 |
0.6 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.1 |
0.5 |
GO:0050904 |
diapedesis(GO:0050904) |
| 0.1 |
0.9 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.1 |
1.7 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 |
0.3 |
GO:2000144 |
positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.1 |
0.5 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 |
0.7 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.1 |
0.5 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.1 |
2.3 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.1 |
0.3 |
GO:0090289 |
regulation of osteoclast proliferation(GO:0090289) |
| 0.1 |
0.7 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.1 |
1.7 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.1 |
0.5 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 |
0.4 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.1 |
2.6 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 |
0.3 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.1 |
0.3 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.1 |
0.2 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.1 |
0.5 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.1 |
3.6 |
GO:0000045 |
autophagosome assembly(GO:0000045) |
| 0.1 |
1.2 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 |
0.4 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
| 0.1 |
2.1 |
GO:0072384 |
organelle transport along microtubule(GO:0072384) |
| 0.1 |
0.8 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 |
0.5 |
GO:0035993 |
deltoid tuberosity development(GO:0035993) |
| 0.1 |
0.2 |
GO:0045627 |
positive regulation of T-helper 1 cell differentiation(GO:0045627) |
| 0.1 |
0.3 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.1 |
2.4 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.1 |
0.3 |
GO:0032096 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.1 |
0.5 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 |
1.9 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.1 |
0.7 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.1 |
0.4 |
GO:0032382 |
positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) positive regulation of cholesterol import(GO:1904109) positive regulation of sterol import(GO:2000911) |
| 0.1 |
0.4 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.1 |
0.7 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.1 |
1.2 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.1 |
0.8 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.1 |
2.9 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.1 |
0.3 |
GO:0002323 |
natural killer cell activation involved in immune response(GO:0002323) |
| 0.1 |
1.6 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.1 |
1.9 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 |
0.2 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.1 |
2.1 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.1 |
0.5 |
GO:0021592 |
fourth ventricle development(GO:0021592) third ventricle development(GO:0021678) initiation of neural tube closure(GO:0021993) |
| 0.1 |
0.4 |
GO:0015871 |
choline transport(GO:0015871) negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 |
0.5 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 |
0.3 |
GO:0010889 |
regulation of sequestering of triglyceride(GO:0010889) positive regulation of sequestering of triglyceride(GO:0010890) sequestering of triglyceride(GO:0030730) |
| 0.1 |
0.2 |
GO:0045762 |
positive regulation of adenylate cyclase activity(GO:0045762) positive regulation of lyase activity(GO:0051349) |
| 0.1 |
3.2 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 |
0.5 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.1 |
0.4 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.1 |
0.1 |
GO:0046098 |
guanine metabolic process(GO:0046098) |
| 0.1 |
0.3 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.1 |
0.9 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.1 |
1.4 |
GO:0043045 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.1 |
0.5 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.1 |
0.6 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 |
0.3 |
GO:0042891 |
antibiotic transport(GO:0042891) |
| 0.1 |
0.7 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
0.7 |
GO:0097341 |
inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.1 |
0.4 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.1 |
0.3 |
GO:0051189 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.1 |
0.1 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 |
0.3 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 0.1 |
1.2 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.1 |
0.8 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.1 |
0.6 |
GO:0036120 |
response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.1 |
1.3 |
GO:0051569 |
regulation of histone H3-K4 methylation(GO:0051569) |
| 0.1 |
0.8 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 |
0.7 |
GO:0097576 |
autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
| 0.1 |
0.5 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.1 |
0.3 |
GO:0072176 |
nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
| 0.1 |
0.2 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.1 |
1.0 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.1 |
2.7 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.1 |
1.0 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 |
4.7 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.1 |
8.9 |
GO:0071805 |
potassium ion transmembrane transport(GO:0071805) |
| 0.1 |
0.4 |
GO:0071635 |
negative regulation of transforming growth factor beta production(GO:0071635) |
| 0.1 |
1.8 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 |
0.5 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.1 |
0.7 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.1 |
1.7 |
GO:0051647 |
nucleus localization(GO:0051647) |
| 0.1 |
1.2 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.1 |
1.4 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.1 |
1.2 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.1 |
0.1 |
GO:0071455 |
cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) cellular response to hyperoxia(GO:0071455) |
| 0.1 |
0.7 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
3.5 |
GO:0035904 |
aorta development(GO:0035904) |
| 0.1 |
1.0 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.1 |
0.3 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.1 |
0.4 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
0.5 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 |
0.4 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 0.1 |
0.4 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
0.7 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.1 |
GO:0002589 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
| 0.1 |
1.8 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.1 |
8.5 |
GO:0007018 |
microtubule-based movement(GO:0007018) |
| 0.1 |
1.7 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 |
0.1 |
GO:0032276 |
regulation of gonadotropin secretion(GO:0032276) |
| 0.1 |
0.4 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 |
1.4 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.1 |
3.6 |
GO:0099643 |
neurotransmitter secretion(GO:0007269) presynaptic process involved in chemical synaptic transmission(GO:0099531) signal release from synapse(GO:0099643) |
| 0.1 |
0.3 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.1 |
0.3 |
GO:0052490 |
suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) response to cycloheximide(GO:0046898) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 0.1 |
0.6 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.1 |
0.9 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 |
5.9 |
GO:0098792 |
xenophagy(GO:0098792) |
| 0.1 |
0.4 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.1 |
0.3 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 |
0.5 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
2.8 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.1 |
1.6 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.1 |
1.7 |
GO:0006829 |
zinc II ion transport(GO:0006829) |
| 0.1 |
0.2 |
GO:0048715 |
negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.1 |
0.4 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 |
0.5 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.1 |
0.4 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
0.2 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.1 |
0.6 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
0.1 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.1 |
0.3 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.1 |
0.9 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 |
0.2 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 |
1.1 |
GO:0090277 |
positive regulation of peptide secretion(GO:0002793) positive regulation of peptide hormone secretion(GO:0090277) |
| 0.0 |
0.2 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.0 |
0.1 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.0 |
0.4 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.0 |
1.2 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.2 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.0 |
0.5 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.0 |
0.7 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.0 |
1.1 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.5 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.0 |
0.2 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.0 |
0.6 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.0 |
0.5 |
GO:0050806 |
positive regulation of synaptic transmission(GO:0050806) |
| 0.0 |
0.3 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.0 |
1.5 |
GO:0050729 |
positive regulation of inflammatory response(GO:0050729) |
| 0.0 |
0.2 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.0 |
0.5 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
3.5 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.0 |
0.1 |
GO:0055091 |
phospholipid homeostasis(GO:0055091) |
| 0.0 |
0.2 |
GO:0043585 |
nose morphogenesis(GO:0043585) |
| 0.0 |
1.5 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.0 |
0.6 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.6 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.0 |
0.2 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.0 |
0.1 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.0 |
0.2 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.0 |
0.2 |
GO:0032727 |
positive regulation of interferon-alpha production(GO:0032727) |
| 0.0 |
0.6 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.6 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.0 |
0.3 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.0 |
0.7 |
GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 0.0 |
0.9 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.0 |
0.5 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.0 |
0.4 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.0 |
0.3 |
GO:2000505 |
regulation of energy homeostasis(GO:2000505) |
| 0.0 |
0.1 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.3 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.0 |
0.0 |
GO:0042271 |
positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.0 |
0.4 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.0 |
0.3 |
GO:0034088 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.0 |
0.4 |
GO:0015844 |
monoamine transport(GO:0015844) |
| 0.0 |
0.1 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.0 |
0.9 |
GO:0043631 |
RNA polyadenylation(GO:0043631) |
| 0.0 |
0.1 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.0 |
0.2 |
GO:0006273 |
lagging strand elongation(GO:0006273) |
| 0.0 |
0.1 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.0 |
1.1 |
GO:0014065 |
phosphatidylinositol 3-kinase signaling(GO:0014065) |
| 0.0 |
0.2 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.0 |
0.3 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 |
0.1 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 |
0.0 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.0 |
0.1 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.0 |
0.1 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.0 |
0.1 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.0 |
0.2 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.0 |
0.0 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.0 |
0.9 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.0 |
0.2 |
GO:0008209 |
androgen metabolic process(GO:0008209) |
| 0.0 |
0.1 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.0 |
0.2 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.0 |
0.2 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
0.4 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 |
0.1 |
GO:0042659 |
regulation of cell fate specification(GO:0042659) |
| 0.0 |
1.5 |
GO:0050890 |
cognition(GO:0050890) |
| 0.0 |
0.3 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.0 |
0.2 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.0 |
0.9 |
GO:0000956 |
nuclear-transcribed mRNA catabolic process(GO:0000956) |
| 0.0 |
0.3 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
